MBX Biosciences(MBX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MBX MBX Biosciences

Post-Mkt 09-22 18:47:33 EDT

61.98

+1.04

+1.71%

盘后62.00

+0.02+0.03%

18:01 EDT

High63.45	Low60.84	Vol433.36K
Open61.14	D1 Closing60.94	Amplitude4.28%
Mkt Cap2.98B	Tradable Cap1.71B	Total Shares48.16M
T/O26.83M	T/O Rate1.57%	Tradable Shares27.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MBX","market":"US","secType":"STK","nameCN":"MBX Biosciences","latestPrice":61.98,"timestamp":1790107200000,"preClose":60.94,"halted":0,"volume":433357,"hourTrading":{"tag":"盘后","latestPrice":62,"preClose":61.98,"latestTime":"18:01 EDT","volume":33025,"amount":2046900.7285,"timestamp":1790114506607,"change":0.02,"changeRate":0.000323,"amplitude":0.016457},"delay":0,"changeRate":0.017065966524450266,"floatShares":27629899,"shares":48160096,"eps":-2.4052,"marketStatus":"Post-Mkt","change":1.04,"latestTime":"09-22 18:47:33 EDT","open":61.14,"high":63.45,"low":60.84,"amount":26825190.921442,"amplitude":0.042829,"askPrice":63,"askSize":100,"bidPrice":60.77,"bidSize":32,"shortable":3,"etf":0,"ttmEps":-2.4052,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790121600000},"marketStatusCode":4,"adr":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":60.94,"preHourTrading":{"tag":"盘前","latestPrice":62.5,"preClose":60.94,"latestTime":"09:25 EDT","volume":231,"amount":14196.799848,"timestamp":1790083500031,"change":1.56,"changeRate":0.025599,"amplitude":0.040039},"postHourTrading":{"tag":"盘后","latestPrice":62,"preClose":61.98,"latestTime":"18:01 EDT","volume":33025,"amount":2046900.7285,"timestamp":1790114506607,"change":0.02,"changeRate":0.000323,"amplitude":0.016457},"volumeRatio":0.469205,"impliedVol":0.9713,"impliedVolPercentile":0.6175},"requestUrl":"/m/hq/s/MBX/tweets","defaultTab":"tweets","newsList":[{"id":"2666389205","title":"MBX Biosciences to Present at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666389205","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666389205?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:08","pubTimestamp":1788955685,"startTime":"0","endTime":"0","summary":"MBX Biosciences to present at Morgan Stanley Global Healthcare ConferenceMBX Biosciences will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 16, 2026 in New York.Manag","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL2hB8Zp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2347655156.SGD","LU0158827781.USD","LU2487616109.SGD","IE00BKPKM429.USD","LU2264538146.SGD","LU1668664300.SGD","BK4007","IE00BQXX3D17.EUR","LU2133065610.SGD","LU0267386448.USD","MBX","LU0106831901.USD","KBWB","BK4588","LU1548497426.USD","LU2089283258.USD","SF","SG9999014005.SGD","IAI","LU1989772840.SGD","LU0795875169.SGD","LU1064131342.USD","LU1720051017.SGD","LU2357305700.SGD","BCDF","LU1074936037.SGD","LU2271345857.HKD","LU0225283273.USD","IE00BQXX3F31.USD","LU0106261372.USD","IE00BN0W2W23.USD","LU0320765646.SGD","IE00BZ1G4Q59.USD","LU0557290698.USD","IE00BGHQF748.EUR","NDAQ","LU2111349929.HKD","BK4534","IE00B3QW5Z07.USD","BK4504","LU1244550494.USD","LU1791710400.SGD","SG9999014013.SGD","LU1244550577.SGD","BK4581","SG9999014039.USD","IE00B3S45H60.SGD","LU1732800096.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533169","title":"MBX Biosciences to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533169","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533169?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"CARMEL, Ind., and BURLINGTON, Mass., Sept.  09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and comme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358552/0/en/mbx-biosciences-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320319","title":"Mbx Biosciences Announces Appointment of Jeff Held as Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320319?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:00","pubTimestamp":1788868805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA8QWKM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320366","title":"Press Release: MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320366","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320366?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:00","pubTimestamp":1788868800,"startTime":"0","endTime":"0","summary":"CARMEL, Ind. and BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commerc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4555","TM","BK4604","BK4099","BK4585","03160","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662001117","title":"MBX Biosciences Begins Pivotal Phase 3 Canvuparatide Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662001117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662001117?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:58","pubTimestamp":1787835530,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. ( ($MBX) ) just unveiled an update. On August 27, 2026, MBX Biosciences announced that the first patient had been dosed in it...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-begins-pivotal-phase-3-canvuparatide-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-begins-pivotal-phase-3-canvuparatide-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662970289","title":"MBX Biosciences Doses First Patient in Phase 3 oPTimize Trial of Once-Weekly Canvuparatide for Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2662970289","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662970289?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832053,"startTime":"0","endTime":"0","summary":"MBX Biosciences doses first patient in Phase 3 oPTimize trial of once-weekly canvuparatide for hypoparathyroidismMBX Biosciences started dosing patients in its pivotal Phase 3 oPTimize trial of once-w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL1HDw35:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","BCDF","BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4112","BK4585","IE00BKPKM429.USD","MBX","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662704077","title":"Mbx Biosciences, - Phase 3 Optimize Trial to Enroll About 160 Adults with Hypoparathyroidism","url":"https://stock-news.laohu8.com/highlight/detail?id=2662704077","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662704077?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:00","pubTimestamp":1787832002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA9JP4QW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661924292","title":"MBX Biosciences Price Target Announced at $88.00/Share by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661924292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661924292?lang=en_us&edition=fundamental","pubTime":"2026-08-22 03:12","pubTimestamp":1787339520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MBX/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSI","EBS","MCHP","MU","MRVL","FTAI","SMHX","LYTS","LMB","ECG","BCAL","APP","LEGR","IXN","HCAT","AAP","COTY","FIX","FTH","INNV","ADSK","AMP","HL","CHAT","AMYY","DV","MATW","ABT","P","VEGI","AVGU","ADI","QBTS","AVGO","PI","TRFK","AMD","EGGY","HRZN","BWMN","CTEV","MBX","GTLB","DE","DOCS","BAI","DISK","IMA","ACEL","FERG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659122699","title":"13D Filings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659122699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659122699?lang=en_us&edition=fundamental","pubTime":"2026-08-15 07:06","pubTimestamp":1786748760,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTE","SI","BK4228","BK4007","BK4023","STCE","UMH","BK4211","BK4608","BK4082","BK4215","MBX","BK4213","BK4116","CORZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658398734","title":"Truist Adjusts Price Target on MBX Biosciences to $88 From $70, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658398734","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658398734?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:11","pubTimestamp":1786356711,"startTime":"0","endTime":"0","summary":"MBX Biosciences (MBX) has an average rating of buy and mean price target of $88.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657362993","title":"MBX Biosciences, Inc. (MBX) Gets a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2657362993","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657362993?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:55","pubTimestamp":1786136131,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on MBX Biosciences, Inc. today and set a price target of $91.00. According to TipRanks, Ea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mbx-biosciences-inc-mbx-gets-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mbx-biosciences-inc-mbx-gets-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MBX","MFG","GSIB","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657612918","title":"MBX Biosciences price target raised to $88 from $70 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2657612918","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657612918?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:21","pubTimestamp":1786098101,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on MBX Biosciences (MBX) to $88 from $70 and keeps an Overweight rating on the shares. The firm updated the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-price-target-raised-to-88-from-70-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mbx-biosciences-price-target-raised-to-88-from-70-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656758","title":"Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656758?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:50","pubTimestamp":1786035024,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-billiontoone-inc-class-a-blln-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-billiontoone-inc-class-a-blln-and-mbx-biosciences-inc-mbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLLN","NA","BK4196","MBX","BK4007","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657180658","title":"MBX Biosciences Shares Lower After Q2 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657180658","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657180658?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:40","pubTimestamp":1786027259,"startTime":"0","endTime":"0","summary":"MBX Biosciences  shares were about 1.0% lower in Thursday trading following its Q2 results.Earlier, the clinical-stage biopharmaceutical company reported a Q2 net loss of $0.78 per share, compared with a loss of $0.58 a year ago.Looking ahead, the firm said its cash and investments are expected to support operations into 2029.Price: 66.78, Change: -0.70, Percent Change: -1.04","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657541637","title":"MBX Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657541637","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657541637?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:47","pubTimestamp":1786024062,"startTime":"0","endTime":"0","summary":"MBX Biosciences, Inc. reports results for the quarter ended June 30 - Earnings SummaryMBX Biosciences, Inc.MBX.OQreported a quarterly adjusted loss of 78 cents per share for the quarter ended June 30,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N443229:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657118631","title":"MBX Biosciences Advances Canvuparatide and Obesity Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657118631","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657118631?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:41","pubTimestamp":1786020108,"startTime":"0","endTime":"0","summary":"An announcement from MBX Biosciences, Inc. ( ($MBX) ) is now available. MBX Biosciences reported its second-quarter 2026 results on August 6, 2026,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-advances-canvuparatide-and-obesity-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mbx-biosciences-advances-canvuparatide-and-obesity-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657063991","title":"Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2657063991","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657063991?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:12","pubTimestamp":1786018336,"startTime":"0","endTime":"0","summary":"Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639558","title":"MBX Biosciences Posts Corporate Presentation on Precision Peptide Programs for Endocrine, Metabolic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639558","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639558?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:11","pubTimestamp":1786018268,"startTime":"0","endTime":"0","summary":"MBX Biosciences posts corporate presentation on precision peptide programs for endocrine, metabolic diseasesMBX Biosciences outlined a catalyst schedule led by canvuparatide (MBX 2109) Phase 3 initiat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL7Xfsrm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657563989","title":"MBX Biosciences Q2 FY26 Net Loss Widens to $37.1 Million; R&D Expenses Rise to $31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657563989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657563989?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:08","pubTimestamp":1786018099,"startTime":"0","endTime":"0","summary":"MBX Biosciences Q2 FY26 net loss widens to $37.1 million; R&D expenses rise to $31 millionMBX Biosciences posted a Q2 net loss of USD 37.1 million, widening from USD 19.4 million a year earlier.R&D ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3ctvVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mbxbio.com","stockEarnings":[{"period":"1week","weight":0.0244},{"period":"1month","weight":-0.0813},{"period":"3month","weight":0.3136},{"period":"6month","weight":1.1043},{"period":"1year","weight":5.094},{"period":"ytd","weight":0.9321}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0544},{"period":"6month","weight":0.1776},{"period":"1year","weight":0.1654},{"period":"ytd","weight":0.1343}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MBX Biosciences, Inc. was incorporated in August 2018 as an Indiana limited liability company and converted to a Delaware corporation in April 2019. The company is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel precision peptide therapeutics for endocrine and metabolic disorders. Its pipeline includes drug candidates for hypoparathyroidism, obesity, and post-bariatric hypoglycemia, designed using its proprietary Precision Endocrine Peptide (PEP) platform.","exchange":"NASDAQ","name":"MBX Biosciences","nameEN":"MBX Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MBX Biosciences(MBX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MBX Biosciences(MBX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MBX Biosciences,MBX,MBX Biosciences股票,MBX Biosciences股票老虎,MBX Biosciences股票老虎国际,MBX Biosciences行情,MBX Biosciences股票行情,MBX Biosciences股价,MBX Biosciences股市,MBX Biosciences股票价格,MBX Biosciences股票交易,MBX Biosciences股票购买,MBX Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MBX Biosciences(MBX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MBX Biosciences(MBX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}